Skip to main content
OpenTrials
Completed

NCT Number: NCT02752997

Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services

Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases Patient Readmission

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic Health System - Franciscan Healthcare

La Crosse, Wisconsin, 54601, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of heart failure, discharged from any medical service

Exclusion criteria

  • Unwilling to participate, discharged to nursing/rehab facility, non-English speaking, resident unavailable

Treatment and study plan

Pharmacist discharge medication services

Other

Included in arm descriptions

Primary outcomes

  1. Number of patients readmitted to the hospital within 30 days of primary heart failure admission

    Time frame: 30 Days

    Fisher's T-test

Secondary outcomes

  1. Number of patients who visit the emergency department within 30 days of primary heart failure admission

    Time frame: 30 Days

    Fisher's T-test

  2. Number of medication discrepancies identified and the number of medication discrepancies resolved by the pharmacist at discharge.

    Time frame: 30 Days

    Fisher's T-test

  3. Number of short term goals set by patient's at discharge and the number of short term goals met by patient's at the 7-10 follow up phone call.

    Time frame: 30 days

    Number of short term goals set will be compared to the number of goals patients achieved, comparison will be calculated by percentage

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Apr 27, 2016
Registry last updated
Apr 27, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.